drugset / Trial / NCT01556997

Perindopril Amlodipine for the Treatment of Hypertension

NCT01556997

Phase 3 Completed 837 enrolled Symplmed Pharmaceuticals LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the safety and efficacy of a fixed-dose combination drug compared to two other drugs (monotherapies) in controlling hypertension.

Timeline

Start
2012-02
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified Oral
Comparator Perindopril Small molecule Oral